Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults

on behalf of the UK NCRI AML Trial Group, on behalf of the HOVON AML Trial Group

Research output: Contribution to journalLetterAcademicpeer-review

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)130-133
JournalBritish journal of haematology
Issue number1
Publication statusPublished - 1 Jul 2019


  • acute leukaemia
  • flow cytometry
  • measurable residual disease

Cite this